医思健康（02138）于2025年12月3日公布截至2025年11月30日的股份变动月报表。报告显示，公司法定注册股本仍为38,000,000,000股普通股（面值每股0.00001港元），注册股本总额维持在380,000港元。公司已发行股份数量同样保持不变，报1,185,211,265股，无库藏股记录。
期权和认股权证方面，截至报告期末，根据2016年及2023年股东大会通过的购股权计划，合计78,223,063份购股权处于有效状态；另有本金总额为36,400,000港元的OrbiMed认股权证尚未行使，可对应5,899,513股。在可换股债券方面，公司仍持有本金总额合计265,200,000港元的可转换债券，如果全部转换，可对应约46,977,234股普通股。
公告同时确认公司于2025年11月间无新增股份发行或购回交易；截至本月末，总股本维持稳定。公司声明所有发行、授权及潜在股份变动均已获得董事会批准，并遵守香港联交所《上市规则》及相关法律规定。公告由公司秘书萧镇邦签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.